Brevet
Private Company
Total funding raised: $15M
Overview
Brevet is a precision engineering and contract manufacturing firm focused on critical fluid connection components for medical, biopharmaceutical, and industrial markets. Founded in 2026 and operating from New York, the company provides application-specific, 100% US-made components such as connectors, adapters, and custom syringe solutions, emphasizing material mastery and stringent quality control. As a service-oriented manufacturer, Brevet accelerates innovation for its clients by offering optimized manufacturing processes, minimal lead times, and components that meet high regulatory standards for performance and safety. Its business model is built on contract manufacturing services rather than developing its own therapeutic products.
Technology Platform
Precision injection molding and material science platform specializing in medical-grade polycarbonate and PVC for manufacturing critical fluid connection components (connectors, adapters, fittings, custom assemblies). Integrates advanced manufacturing processes with stringent quality control (ISO 13485, FDA standards) for regulated industries.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Brevet operates in a highly competitive market populated by large global contract manufacturers (e.g., Nordson MEDICAL, Teleflex, B. Braun) and numerous smaller specialty molders. It differentiates through a focused expertise in fluid connectors, deep material science knowledge, a strong 'Made in USA' appeal, and its certifications for medical markets. Competitors may have greater scale, broader global reach, or lower cost structures.